Vacancy rates have risen and occupancy has shrunk for office space in MetroWest, according to a third-quarter report by Perry Brokerage Associates of Boston.
New Jersey medical behemoth Johnson & Johnson could be eyeing Marlborough medical device giant Boston Scientific, according to a recent analyst report.
Marlborough medical device giant Boston Scientific has been approved by U.S. regulators to market a device that helps deliver a sustained release of a drug to treat peripheral artery disease.
The Point at Marlborough, a residential community off Brigham Street has sold for $65 million, a number that could set a high price mark for the year for Central Massachusetts.
A Marlborough hedge fund adviser and his investment firm are being charged with profiting more than $1.3 million after driving down the price of a California pharmaceutical company.